Effect of tramadol on immune responses and nociceptive thresholds in a rat model of incisional pain

Objective: To evaluate the effects oftramadol on the proinflammatory responses in a rat model of incisional pain by investigating its effects on nociceptive thresholds and serum interleukin-6 (IL-6) and IL-2 levels. Methods: Forty-two male Sprague-Dawley (SD) rats scheduled for plantar incision were randomly divided into 7 groups (n=6 in each group). Rats in Group 1 receiving general anesthesia with no incision were served as control; At 30 min before skin incision, Groups 2～5 were given 5 ml normal saline or 1, 10, and 20 mg/kg tramadol, respectively, intraperitoneally (i.p.); Group 6 received 10 mg/kg tramadol after operation; Group 7 received 10 mg/kg tramadol before incision, followed by 200 μg/kg naloxone after operation. Mechanical allodynia was measured by electronic von Frey filament to evaluate the nociceptive thresholds 1 h before incision, and 1 h and 2 h after operation. Serum IL-6 and IL-2 levels were measured by enzyme-linked immunosorbent assay (ELISA) 2 h after operation. Results: Mechanical thresholds decreased significantly and serum IL-6 level increased significantly after operation in Group 2 compared with control (P＜0.01), and these changes were reversed respectively by tramadol in a dose-dependent manner (P＜0.05 and P＜0.01, respectively). IL-2 level remained unchanged after operation in Group 2, but decreased in Group 3 (P＜0.05), then gradually returned to the normal level in Groups 4 and 5. The intraperitoneally injected tramadol (10 and 20 mg/kg) produced a potent and dose-dependent antinocicptive effect on the lesioned paw. The antinocicptive effects of tramadol were partially an-tagonized by naloxone (200 μg/kg), suggesting an additional non-opioid mechanism. Conclusion: The results suggest that tramadol could be a good choice for the treatment of pain under the conditions that immunosuppression may be particularly contraindicated.     

Effect of nitrogen doping on the reduction of nitric oxide with activated carbon in the presence of oxygen

Nitrogen doping of activated carbon （AC） was performed by annealing both in ammonia and nitric oxide, and the activities of the modified carbons for NO reduction were studied in the presence of oxygen. Results show that nitrogen atoms were incorporated into the carbons, mostly in the form of pyridinic nitrogen or pyridonic nitrogen. The effect of nitrogen doping on the activities of the carbons can be ignored when oxygen is absent, but the doped carbons show desirable activities in the low temperature regime （≤500 ℃） when oxygen is present. The role of the surface nitrogen species is suggested to promote the formation of NO2 in the presence of oxygen, and NO2 can facilitate decomposition of the surface oxygen species in the low temperature regime     

Science Letters:Effect of nitrogen doping on the reduction of nitric oxide with activated carbon in the presence of oxygen

Nitrogen doping of activated carbon (AC) was performed by annealing both in ammonia and nitric oxide, and the activities of the modified carbons for NO reduction were studied in the presence of oxygen. Results show that nitrogen atoms were incorporated into the carbons, mostly in the form of pyridinic nitrogen or pyridonic nitrogen. The effect of nitrogen doping on the activities of the carbons can be ignored when oxygen is absent, but the doped carbons show desirable activities in the low temperature regime (≤500 ℃) when oxygen is present. The role of the surface nitrogen species is suggested to promote the formation of NO2 in the presence of oxygen, and NO2 can facilitate decomposition of the surface oxygen species in the low temperature regime.     

Study on the neurotoxic effects of low-level lead exposure in rats

Objective: To investigate effects of developmental lead exposure on nitric oxide synthase (NOS) activity in different brain regions and on N-methyl-D-aspartate (NMDA) receptor mRNA expression in the hippocampus of rats. On the basis of these observations, we explored possible mechanisms by which lead exposure leads to impaired learning and memorizing abilities in children. Methods: A series of rat animal models exposed to low levels of lead during the developing period was established (drinking water containing 0.025%, 0.05% and 0.075% lead acetate). NOS activities in the hippocampus, the cerebral cortex, the cerebellum and the brain stem were determined with fluorescence measurement and levels of mRNA expression of the NMDA receptor 2A (NR2A) subunit and NMDA receptor 2B (NR2B) subunit in the rat hippocampus were measured with Retro-translation (RT-PCR). Results: There were no differences in the body weight of rat pups between any of the groups at any given time (P>0.05). The blood lead level of Pb-exposed rat pups showed a systematic pattern of change: at 14 d of age, it was lower than that at 7 d of age, then rising to the peak level at 21 d and finally falling to lower levels at 28 d. The hippocampal NOS activities of lead-exposed groups were all lower than that of the control group on the 21st and 28th day (P<0.01). NOS activities in the cerebellum of lead-exposed groups were all lower than that of the control group on the 21st and 28th day (P<0.001) and the NOS activity of the 0.025% group was significantly lower than that of the 0.05% and 0.075% groups on the 28th day (P<0.05). NOS activity in the cerebral cortex of the 0.075% group was significantly lower than that of the control, 0.025% and 0.05% groups on the four day spans (P<0.001). There was no significant difference of NOS activity in the brain stem between any lead-exposed group and the control group on the four day spans. In the 0.05% and the 0.075% groups, the level of NR2A mRNA expression was higher than that in the control group at 7 d and 14 d of age (P<0.05). In the 0.025% group, the level of NR2A was found to be higher than that in the control group at 7 d of age only (P<0.05). No significant differences were found for the levels of NR2B mRNA expression between any of the groups at any given time. Conclusions: NOS activity in the hippocampus, the cerebral cortex and the cerebellum are inhibited by lead exposure. The degree of the inhibitory effect depends on the time span of exposure and the lead concentration. Developmental low-level lead exposure was found to raise the level of NR2A mRNA expression in the hippocampus of rats. Developmental low-level lead exposure does not affect the level of NR2B mRNA expression in the hippocampus.